Bleomycin toxicity simulating metastatic nodules to the lungs
- 1 September 1981
- Vol. 48 (5) , 1096-1100
- https://doi.org/10.1002/1097-0142(19810901)48:5<1096::aid-cncr2820480508>3.0.co;2-y
Abstract
Pulmonary nodules may develop following bleomycin therapy, a previously undescribed entity that may simulate metastatic disease. Two asymptomatic patients are reported with nodules that developed following low dose bleomycin treatment for testicular tumors. One patient had previously documented pulmonary metastases that had resolved after chemotherapy. The other patient had nodular-appearing densities on routine chest examination without a history of previous metastatic lung involvement.This publication has 16 references indexed in Scilit:
- Routine Pulmonary Function Tests During Bleomycin TherapyPublished by American Medical Association (AMA) ,1980
- Bleomycin lung damage: The pathology and nature of the lesionRespiratory Medicine, 1978
- Cytotoxic drug-induced lung diseaseThe American Journal of Medicine, 1977
- Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancerCancer, 1976
- Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue responsePublished by American Medical Association (AMA) ,1976
- Large-Dose Bleomycin Therapy and Pulmonary ToxicityPublished by American Medical Association (AMA) ,1976
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- The Pulmonary Changes of Bleomycin ToxicityRadiology, 1973
- Interstitial Pneumonitis Associated with Bleomycin TherapyAmerican Journal of Clinical Pathology, 1972
- Clinical trials with bleomycin in lymphomas and in solid tumorsPublished by Elsevier ,1972